* The US Food and Drug Administration on Wednesday, April 1st 2020 granted Emergency Use Authorization (EUA) to Ipsum Diagnostics for the company’s RT-PCR-based SARS-CoV-2 test. The FDA EUA increased our testing capacity processing from 1000 to 4000 tests per day.

Total Reported: 437,300

Received 
(7 day average)

5832

Reported
(7 day average)

7105

Turnaround
(7 day average)

1.4 Days

Please email our courier service department for fast and reliable specimen pickup and transfer.

NEWS & RESOURCES